In conclusion, we found that miR-200c over-expression could reverse the mesenchymal phenotype of cells to epithelial phenotype by targeting ZEB1 in NSCLC, which could also re-sensitize EGFR-TKIs in NSCLC cell lines with primary resistance. The gene discussed is ZEB1; the disease is non-small cell lung carcinoma.